News Focus
News Focus
icon url

DewDiligence

11/17/13 4:16 PM

#170093 RE: mcbio #170092

As I said, the assumption is to keep things simple. In any case, Simeprevir + Sofosbuvir will have too small a worldwide market share in 2015-2016 to make much difference, IMO.